Abstract
DP-b99 is a membrane-activated chelator of zinc and calcium ions, recently proposed as a therapeutic agent. Matrix metalloproteinases (MMPs) are zinc-dependent extracellularly operating proteases that might contribute to synaptic plasticity, learning and memory under physiological conditions. In excessive amounts these enzymes contribute to a number of neuronal pathologies ranging from the stroke to neurodegeneration and epileptogenesis. In the present study, we report that DP-b99 delays onset and severity of PTZ-induced seizures in mice, as well as displays neuroprotective effect on kainate excitotoxicity in hippocampal organotypic slices and furthermore blocks morphological reorganization of the dendritic spines evoked by a major neuronal MMP, MMP-9. Taken together, our findings suggest that DP-b99 may inhibit neuronal plasticity driven by MMPs, in particular MMP-9, and thus may be considered as a therapeutic agent under conditions of aberrant plasticity, such as those subserving epileptogenesis.
| Original language | English |
|---|---|
| Article number | e99789 |
| Pages (from-to) | 1-9 |
| Number of pages | 9 |
| Journal | PLoS ONE |
| Volume | 9 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 11 Jun 2014 |
| Externally published | Yes |
Keywords
- Animals
- Chelating Agents
- Dendritic Spines
- Egtazic Acid
- Hippocampus
- Kainic Acid
- Male
- Matrix Metalloproteinase 9
- Mice
- Mice, Inbred C57BL
- Neuronal Plasticity
- Seizures
- Journal Article
- Research Support, Non-U.S. Gov't
Fingerprint
Dive into the research topics of 'DP-b99 modulates matrix metalloproteinase activity and neuronal plasticity'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver